SpringWorks Therapeutics Market Outlook
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
Slightly above 56% of SpringWorks Therapeutics' investor base is looking to short. The analysis of current outlook of investing in SpringWorks Therapeutics suggests that many traders are alarmed regarding SpringWorks Therapeutics' prospects. SpringWorks Therapeutics' investing sentiment can be driven by a variety of factors including economic data, SpringWorks Therapeutics' earnings reports, geopolitical events, and overall market trends.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use SpringWorks Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward SpringWorks Therapeutics.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding SpringWorks Therapeutics is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell SpringWorks Therapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for SpringWorks Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute SpringWorks Therapeutics Advice
The SpringWorks recommendation should be used to complement the investment advice compiled from the current analysts' consensus on SpringWorks Therapeutics. Macroaxis does not own or have any residual interests in SpringWorks Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute SpringWorks Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
For the selected time horizon SpringWorks Therapeutics has a Risk Adjusted Performance of 0.0244, Jensen Alpha of 0.0244, Total Risk Alpha of (0.26), Sortino Ratio of (0.01) and Treynor Ratio of 0.1377Our trade recommendation tool can be used to complement SpringWorks Therapeutics advice provided by experts. It analyzes the firm's potential to grow against your specific risk preferences and investment horizon. To make sure SpringWorks Therapeutics is not overpriced, please validate all SpringWorks Therapeutics fundamentals, including its cash per share, short ratio, and the relationship between the ebitda and current ratio . Given that SpringWorks Therapeutics has a number of shares shorted of 6.38 M, we advise you to double-check SpringWorks Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.
SpringWorks Therapeutics Trading Alerts and Improvement Suggestions
| SpringWorks Therapeutics is not yet fully synchronised with the market data | |
| SpringWorks Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 191.59 M. Net Loss for the year was (258.13 M) with profit before overhead, payroll, taxes, and interest of 204.8 M. | |
| SpringWorks Therapeutics currently holds about 334.54 M in cash with (175.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.81. | |
| Over 87.0% of the company shares are owned by institutional investors |
SpringWorks Therapeutics Returns Distribution Density
The distribution of SpringWorks Therapeutics' historical returns is an attempt to chart the uncertainty of SpringWorks Therapeutics' future price movements. The chart of the probability distribution of SpringWorks Therapeutics daily returns describes the distribution of returns around its average expected value. We use SpringWorks Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of SpringWorks Therapeutics returns is essential to provide solid investment analysis for SpringWorks Therapeutics.
| Mean Return | 0.07 | Value At Risk | -6.92 | Potential Upside | 5.93 | Standard Deviation | 3.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of SpringWorks Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 12078 shares by Badreddin Edris of SpringWorks Therapeutics at 54.2582 subject to Rule 16b-3 [view details]
SpringWorks Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as SpringWorks . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 6.0E-4 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 47.0 | |||
| Day Typical Price | 46.99 | |||
| Market Facilitation Index | 0.03 | |||
| Price Action Indicator | (0.01) |
About SpringWorks Therapeutics Buy or Sell Advice
When is the right time to buy or sell SpringWorks Therapeutics? Buying financial instruments such as SpringWorks Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having SpringWorks Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Raw Materials Thematic Idea Now
Raw Materials
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |